NCT03276806

Inpatient Smokers and LDCT Screening RCT

Completed NA Last updated 5 July 2019

What this trial tests

NA trial testing tobacco dependence/smoking cessation counseling in Lung Cancer in 102 participants. Completed in 1 July 2019.

Timeline

7 November 2017

Primary endpoint
1 April 2019

1 July 2019

Quick facts

Lead sponsor	Boston University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	102
Start date	7 November 2017
Primary completion	1 April 2019
Estimated completion	1 July 2019
Sites	1 location across United States

Drugs / interventions tested

• tobacco dependence/smoking cessation counseling
• SDM
• Decision Aid
• LDCT brochure

Conditions studied

• Lung Cancer — all drugs for Lung Cancer →
• Shared Decision Making — all drugs for Shared Decision Making →

Sponsor

Boston University

Who can join

Adults 55 to 80, any sex, with Lung Cancer or Shared Decision Making. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Current smokers who undergo annual low dose CT (LDCT) lung cancer screening and successfully quit smoking derive the greatest reduction in lung cancer mortality. Unfortunately, those at highest risk of lung cancer death- those with low socioeconomic status, blacks, and current smokers- are the same individuals that typically have reduced access to preventive healthcare such as smoking cessation services and screening tests. Furthermore, patients from underserved communities often have lower health literacy, less awareness of lung cancer screening, and a poor understanding of the trade-offs of LDCT screening. In 2015 the Center for Medicare and Medicaid Services began requiring (1) a shared decision-making (SDM) discussion including use of a patient decision aid and (2) smoking cessation counseling in order to receive reimbursement for LDCT screening. There is little guidance, however, to help healthcare systems implement this requirement. Furthermore, primary care physicians (PCPs) report time constraints, competing demands, and knowledge deficiencies as barriers to optimizing utilization of LDCT screening.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials.
   Kathuria H, Gunawan A, Spring M, Aijaz S, et al · · 2022 · cited 8× · PMID 35997854 · DOI 10.1007/s10552-022-01620-8